LEUKOSEP – SOLX A ADDITIVE SOLUTION (Haemonetics Manufacturing Inc)
Welcome to the PulseAid listing for the LEUKOSEP – SOLX A ADDITIVE SOLUTION drug offered from Haemonetics Manufacturing Inc. This Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Haemonetics Manufacturing Inc |
| NON-PROPRIETARY NAME: | SOL A ADDITIVE SOLUTION |
| SUBSTANCE NAME: | ADENINE; MANNITOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Osmotic Activity [MoA],Osmotic Diuretic [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-05-15 |
| END MARKETING DATE: | 0000-00-00 |
LEUKOSEP – SOLX A ADDITIVE SOLUTION HUMAN PRESCRIPTION DRUG Details:
| Item Description | LEUKOSEP – SOLX A ADDITIVE SOLUTION from Haemonetics Manufacturing Inc |
| LABELER NAME: | Haemonetics Manufacturing Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 30; 1.1(mg/80mL; g/80mL) |
| START MARKETING DATE: | 2013-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 53157-303_795f1082-9ede-47cb-9a22-5092787ecbb3 |
| PRODUCT NDC: | 53157-303 |
| APPLICATION NUMBER: | NDA110059 |
Other ADENINE; MANNITOL Pharmaceutical Manufacturers / Labelers:
